Insulet Corporation (FRA:GOV)

Market Cap	15.15B -16.0%
Revenue (ttm)	2.15B +27.1%
Net Income	209.84M -41.5%
EPS	2.94 -39.8%
Shares Out	n/a
PE Ratio	72.18
Forward PE	43.93
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	11
Open	211.20
Previous Close	212.70
Day's Range	211.20 - 215.40
52-Week Range	205.10 - 304.00
Beta	n/a
RSI	28.36
Earnings Date	Feb 18, 2026

About Insulet

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; and Omnipod DASH insulin management system that features a Bluetooth enabled pod that is cont...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 2000
• Employees: 3,900
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: GOV

Financial Performance

In 2024, Insulet's revenue was $2.07 billion, an increase of 22.07% compared to the previous year's $1.70 billion. Earnings were $418.30 million, an increase of 102.76%.

Financial numbers in USD